Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 756 of 6351
-
Can counseling keep homeless youth off opioids?
Prevention Recruiting nowHomelessness severely affects health and well-being and is particularly negative for youth. Between 70-95% of youth experiencing homelessness (YEH) report problem substance use and 66-89% have a mental health disorder. Youth appear to be at greater risk for living on the streets …
Sponsor: Ohio State University • Aim: Prevention
Last updated Jun 27, 2026 07:51 UTC
-
New lung fibrosis pill tested for Long-Term safety in 1,700 patients
Disease control Recruiting nowThis study is open to people with idiopathic pulmonary fibrosis (IPF) or progressive pulmonary fibrosis (PPF). They can only take part if they have completed treatment in a previous study with a medicine called nerandomilast or BI 1015550. The goal of this study is to find out h…
Phase 3 • Sponsor: Boehringer Ingelheim • Aim: Disease control
Last updated Aug 22, 2026 00:00 UTC
-
Two brain zaps may lift the fog of Schizophrenia's negative symptoms
Symptom relief By invitation onlyDysfunction of the dorsolateral prefrontal cortex (DLPFC) is central to the persistence of negative symptoms in schizophrenia. Both HD-tDCS and iTBS targeting the left DLPFC have shown therapeutic benefit. This trial will test the hypothesis that combining HD-tDCS with iTBS yield…
Sponsor: Tri-Service General Hospital (TSGH) • Aim: Symptom relief
Last updated Jul 11, 2026 00:00 UTC
-
Could a talking therapy ease the weight of bipolar depression?
Symptom relief CompletedThe goal of this clinical trial is to test the efficacy of Acceptance and Commitment Therapy (ACT) as a psychotherapeutic treatment for patients with Bipolar Disorder (BD). The following questions will be investigated: * The efficacy of ACT in reducing depressive symptoms in pat…
Sponsor: Beny Lafer • Aim: Symptom relief
Last updated Aug 02, 2026 00:00 UTC
-
A shot at smoother recovery: knee replacement pain blocks put to the test
Symptom relief CompletedThis randomised trial examines the three main anaesthetic blocks used in knee replacement surgery, comparing them in terms of analgesic efficacy (primary outcome), range of motion and degree of flexion in the immediate post-operative period. Other outcomes include medication use…
Sponsor: I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio • Aim: Symptom relief
Last updated Aug 09, 2026 00:00 UTC
-
Can nanotechnology silver beat standard gauze for diabetic foot ulcers?
Disease control CompletedDiabetic foot ulcers are the complication of diabetes most frequently requiring hospitalization and carry very high treatment costs. Ulcers that fail to heal may lead to amputation of the foot or leg, causing permanent disability and major loss of working capacity. Neuropathy, va…
Sponsor: Ankara City Hospital Bilkent • Aim: Disease control
Last updated Aug 13, 2026 00:00 UTC
-
Promising pill may halt vitiligo and bring back pigment
Disease control OngoingVitiligo affects approximately 1 to 2% of the global population and significantly impacts people's quality of life. Achieving the best treatment outcomes for vitiligo involves addressing the autoimmune inflammatory response to stop the depigmentation process and promoting the dif…
Phase 2 • Sponsor: Centre Hospitalier Universitaire de Nice • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC
-
New drug cocktail aims to tackle rare blood cancer
Disease control Recruiting nowThe main purpose of this study to find the ideal dose for the combination treatment of Zanubrutinib and Tafasitamab in patients with mantle cell lymphoma. Another purpose is to assess how well the combination treatment works in patients with the study disease.
Phase 1/2 • Sponsor: Alvaro Alencar, MD • Aim: Disease control
Last updated Jun 27, 2026 07:53 UTC
-
New transplant method aims to cut dangerous side effects in blood cancer patients
Disease control Recruiting nowThis study will assess the safety, efficacy, and feasibility of ⍺/β CD3+ T-cell and CD19+ B-cell depletion in allogeneic stem cell transplantation in patients with acute lymphocytic leukemia (ALL), acute myeloid leukemia (AML), juvenile myelomonocytic leukemia (JMML), high risk m…
Phase 2 • Sponsor: University of Florida • Aim: Disease control
Last updated Jun 27, 2026 13:02 UTC
-
New pill shows promise in slowing advanced breast cancer
Disease control Recruiting nowTo evaluate the efficacy and safety of dalpiciclib in patients with HR-positive/HER2-positive advanced breast cancer.
Sponsor: RenJi Hospital • Aim: Disease control
Last updated Jun 27, 2026 09:01 UTC
-
A sticker-based stomach scan may replace radioactive tests for a chronic digestive disorder
Diagnosis CompletedGastroparesis is a chronic and debilitating gastric disease associated with poor quality of life, psychological distress, frequent hospitalisations, and high healthcare utilization and associated costs. It is defined by persistent upper gastrointestinal symptoms and delayed gastr…
Sponsor: University of Western Sydney • Aim: Diagnosis
Last updated Sep 02, 2026 00:00 UTC
-
New RNA shot directly into tumors could boost immune attack
Disease control Recruiting nowPhase 1/2, Open-label, Multi-center, First-in-human Study of the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Anti-tumor Activity of STX-001 Delivered by Intratumoral Injection in Patients with Advanced Solid Tumors as a Monotherapy or in Combination with Pembroli…
Phase 1/2 • Sponsor: Strand Therapeutics Inc. • Aim: Disease control
Last updated Jun 27, 2026 07:56 UTC
-
Could fewer doses of this prostate cancer drug be just as good?
Disease control PausedThis phase II trial studies how to improve the usage of Lu 177 vipivotide tetraxetan (177Lu-prostate-specific membrane antigen \[PSMA\]-617) for treating patients with castration-resistant prostate cancer that has spread from where it first started (primary site), to other places…
Phase 2 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Aug 22, 2026 00:00 UTC
-
Brain stimulation may boost swallowing recovery after stroke
Disease control By invitation onlyThis randomized, single-blind, controlled clinical trial aims to compare the effectiveness of neuromuscular electrical stimulation (NMES) administered alone or in combination with transcranial direct current stimulation (tDCS) or transcranial magnetic stimulation (TMS) in adults …
Sponsor: Atlas University • Aim: Disease control
Last updated Sep 02, 2026 00:00 UTC
-
Could a common antibiotic beat stubborn joint infections?
Disease control Recruiting nowCutibacterium acnes is involved in nearly 40% of shoulder prosthetic joint infections (PJI). After shoulder prothesis, C. acnes mainly affects hip prosthesis. One recent work from the Lyon (France) bone and joint infections reference center with data focusing mainly on hip and kn…
Phase 3 • Sponsor: Centre Hospitalier Universitaire de Nice • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
Could a glucose monitor and education shield seniors from Insulin's dangerous side?
Disease control Recruiting nowOlder adults with type 2 diabetes are at higher risk for severe hypoglycemia and its related complications (including hospitalization and death) when taking insulin. This study proposes to evaluate, in a randomized clinical trial, a strategy of safe insulin prescribing based on a…
Sponsor: Kaiser Permanente • Aim: Disease control
Last updated Aug 06, 2026 00:00 UTC
-
Experimental cocktail targets deadly brain lymphoma
Disease control Recruiting nowSecondary involvement of the central nervous system (CNS), such as CNS relapse after treatment or progression during treatment, is a rare but deadly occurrence in patients with B-cell non-Hodgkin lymphoma (NHL), particularly in cases of diffuse large B-cell lymphoma (DLBCL) and t…
Phase 1/2 • Sponsor: Samsung Medical Center • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Peer-led prevention: can gancheros help stop HIV, hepatitis c, and overdose in NYC?
Prevention OngoingThe goal of this pilot clinical trial is to learn if an intervention that trains Gancheros (people who provide injection services in exchange for drugs or money) to conduct risk-reduction outreach could help lower risk for human immunodeficiency virus (HIV), hepatitis C virus (HC…
Sponsor: North Jersey AIDS Alliance dba North Jersey Community Research Initiative (NJCRI) • Aim: Prevention
Last updated Jul 26, 2026 00:00 UTC
-
Can a phone app ease stress for chinese americans?
Symptom relief CompletedUsing a three-armed design the investigators will test whether participants in the Mindboba online application experience significantly greater improvements as compared to participants in the active control (online app based on Cognitive Behavioral Therapy) and participants in th…
Phase 2 • Sponsor: IRIS Media Inc • Aim: Symptom relief
Last updated Aug 07, 2026 00:00 UTC
-
Brain training for tiny hearts: can a Game-Like program sharpen young minds after heart surgery?
Disease control OngoingAdvances in prenatal and neonatal care have improved outcomes in children with severe congenital heart disease (CHD). With the increase in survival, neurocognitive problems such as executive functioning (EF) impairments have become more apparent in these children. EF problems hav…
Sponsor: Erasmus Medical Center • Aim: Disease control
Last updated Jul 25, 2026 00:00 UTC